Sign in

CIK 0001903784

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vogenx, Inc.

Sign in to watch
Ticker
VOGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
863697324
Phone
+1 919-659-5677
Business address
3901 BARRETT DRIVE, SUITE 300, RALEIGH, NC, 27609
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-02 Wilkison William Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +155,000 155,000
2026-10-02 Toombs Kenneth John Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2026-10-02 Pieraccini Peter Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2026-10-02 Green James Chief Executive Officer Grant or award · Stock Option (Right to Buy) +155,000 155,000
2026-10-02 DELMAR STEVEN R Chief Financial Officer Grant or award · Stock Option (Right to Buy) +155,000 155,000
2026-10-02 Boris Timothy Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2026-08-13 Pieraccini Peter Director Conversion +42,735 $11.70 $500K 42,735
2026-08-13 Pieraccini Peter Director Conversion · Convertible Promissory Note −0 0
2026-08-13 DELMAR STEVEN R Chief Financial Officer Conversion +4,273 $11.70 $50K 704,273
2026-08-13 DELMAR STEVEN R Chief Financial Officer Conversion · Convertible Promissory Note −0 0

Page 1 of 1 · 10 trades